Skip to main content
. Author manuscript; available in PMC: 2012 Apr 15.
Published in final edited form as: J Acquir Immune Defic Syndr. 2011 Apr 15;56(5):412–419. doi: 10.1097/QAI.0b013e31820fd093

Figure 1. Median atazanavir concentrations during pregnancy and postpartum.

Figure 1

Median atazanavir concentration-time curves for atazanavir without tenofovir subjects (top graph) and atazanavir with tenofovir subjects (bottom graph). The thin solid line represents the expected (50th percentile) concentration-time profile in non-pregnant adults.